From the Departments of Nuclear Medicine.
Pathology.
Clin Nucl Med. 2021 Apr 1;46(4):e216-e217. doi: 10.1097/RLU.0000000000003414.
An 81-year-old man received androgen deprivation therapy for a locally advanced prostate cancer and, 6 months later, a curative radiation therapy. Half a year later, the patient presented with a steeply increased PSA value (32 ng/mL) and a suppressed testosterone level (0.48 nmol/L). The consecutively performed 68Ga-PSMA PET/CT revealed, besides local tumor remains and several PSMA-positive lymph node and soft tissue metastases, an extensive, diffuse PSMA ligand accumulation in the omentum, which was immunohistochemically proven to be a carcinomatosis of prostate cancer. None of the extraprostatic lesions were present in the pretherapeutic PSMA PET 1 year ago.
一位 81 岁男性因局部晚期前列腺癌接受雄激素剥夺治疗,6 个月后接受根治性放疗。半年后,患者 PSA 值急剧升高(32ng/mL),睾酮水平受到抑制(0.48nmol/L)。随后进行的 68Ga-PSMA PET/CT 显示,除局部肿瘤残留和几个 PSMA 阳性淋巴结和软组织转移外,大网膜广泛弥漫性摄取 PSMA 配体,免疫组化证实为前列腺癌的癌转移。在 1 年前的治疗前 PSMA PET 中,没有发现任何前列腺外病变。